Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Johns Hopkins Genomics, |
RCV001543689 | SCV001762386 | uncertain significance | Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4 | 2021-06-21 | criteria provided, single submitter | clinical testing | PARN c.39C>G is absent from a large population dataset and has not been reported in ClinVar nor the literature, to our knowledge. Three bioinformatic tools queried predict that this substitution would be tolerated. The histidine residue at this position is evolutionarily conserved across most mammalian species assessed, however a glutamine is present in a subset of mammalian species. We consider the clinical significance of PARN c.39C>G to be uncertain at this time. |
The Telomere Center at Johns Hopkins, |
RCV003325412 | SCV003840214 | pathogenic | Telomere syndrome | 2022-08-01 | no assertion criteria provided | clinical testing | Classified as pathogenic based on segregation in a family with 2+ affected indiviudals with IPF/bone marrow failure and short telomere length and expert opinion |